Table 3.
Study or subgroup | Prophylaxis used |
Prophylaxis not used |
Weight | Relative risk H-M, Random, 95% CI |
||
---|---|---|---|---|---|---|
Events | Total | Events | Total | |||
Allende et al. (2015) | 12 | 409 | 19 | 384 | 21.7% | 0.59 (0.29; 1.21) |
Baratz et al. (2015) | 27 | 3434 | 33 | 3080 | 42.6% | 0.73 (0.44, 1.22) |
Hacek et al. (2008) | 11 | 912 | 14 | 583 | 17.8% | 0.50 (0.23; 1.10) |
Rao et al. (2008) | 9 | 636 | 20 | 741 | 18% | 0.53 (0.24; 1.14) |
Total (95% CI) | 59 | 5391 | 86 | 4788 | 100% | 0.62 (0.44; 0.86) |
Heterogeneity: tau2 = 0.0; chi2 = 0.9; df = 3 (p = 0.83); I2 = 0%.
Overall test effect: Z = 2.87 (p = 0.004).